437 related articles for article (PubMed ID: 27939301)
21. MB109 as bioactive human bone morphogenetic protein-9 refolded and purified from E. coli inclusion bodies.
Kuo MM; Nguyen PH; Jeon YH; Kim S; Yoon SM; Choe S
Microb Cell Fact; 2014 Feb; 13(1):29. PubMed ID: 24559319
[TBL] [Abstract][Full Text] [Related]
22. Highly efficient production of soluble proteins from insoluble inclusion bodies by a two-step-denaturing and refolding method.
Yang Z; Zhang L; Zhang Y; Zhang T; Feng Y; Lu X; Lan W; Wang J; Wu H; Cao C; Wang X
PLoS One; 2011; 6(7):e22981. PubMed ID: 21829569
[TBL] [Abstract][Full Text] [Related]
23. Integrated refolding techniques for Schistosoma japonicum MTH1 overexpressed as inclusion bodies in Escherichia coli.
Feng Y; Liu L; Wang J; Liu J; Hu W; Wang X; Yang Z
Protein Expr Purif; 2012 Aug; 84(2):181-7. PubMed ID: 22641057
[TBL] [Abstract][Full Text] [Related]
24. Expression, refolding, and characterization of human soluble BAFF synthesized in Escherichia coli.
Cao P; Mei JJ; Diao ZY; Zhang Sq
Protein Expr Purif; 2005 May; 41(1):199-206. PubMed ID: 15802238
[TBL] [Abstract][Full Text] [Related]
25. Penicillin-binding protein 2a of Streptococcus pneumoniae: expression in Escherichia coli and purification and refolding of inclusion bodies into a soluble and enzymatically active enzyme.
Zhao G; Meier TI; Hoskins J; Jaskunas SR
Protein Expr Purif; 1999 Jul; 16(2):331-9. PubMed ID: 10419829
[TBL] [Abstract][Full Text] [Related]
26. Solubilization and refolding of bacterial inclusion body proteins.
Singh SM; Panda AK
J Biosci Bioeng; 2005 Apr; 99(4):303-10. PubMed ID: 16233795
[TBL] [Abstract][Full Text] [Related]
27. Expression of foreign proteins in Escherichia coli by fusing with an archaeal FK506 binding protein.
Ideno A; Furutani M; Iwabuchi T; Iida T; Iba Y; Kurosawa Y; Sakuraba H; Ohshima T; Kawarabayashi Y; Maruyama T
Appl Microbiol Biotechnol; 2004 Mar; 64(1):99-105. PubMed ID: 14564491
[TBL] [Abstract][Full Text] [Related]
28. Efficient In Vitro Refolding and Characterization of Major Histocompatibility Complex Class I-Related Chain Molecules A (MICA) and Natural Killer Group 2 Member D (NKG2D) Expressed in E. coli.
Zhao X; Acheampong DO; Wang Y; Tang M; Xie W; Chen Z; Wang M; Zhang J
Protein Pept Lett; 2015; 22(5):460-9. PubMed ID: 25925769
[TBL] [Abstract][Full Text] [Related]
29. Strategy for linker selection to enhance refolding and bioactivity of VAS-TRAIL fusion protein based on inclusion body conformation and activity.
Fan J; Huang L; Sun J; Qiu Y; Zhou J; Shen Y
J Biotechnol; 2015 Sep; 209():16-22. PubMed ID: 26072465
[TBL] [Abstract][Full Text] [Related]
30. Efficient production of a correctly folded mouse α-defensin, cryptdin-4, by refolding during inclusion body solubilization.
Tomisawa S; Sato Y; Kamiya M; Kumaki Y; Kikukawa T; Kawano K; Demura M; Nakamura K; Ayabe T; Aizawa T
Protein Expr Purif; 2015 Aug; 112():21-8. PubMed ID: 25913370
[TBL] [Abstract][Full Text] [Related]
31. Purification and refolding of a novel cancer/testis antigen BJ-HCC-2 expressed in the inclusion bodies of Escherichia coli.
Yang XA; Dong XY; Li Y; Wang YD; Chen WF
Protein Expr Purif; 2004 Feb; 33(2):332-8. PubMed ID: 14711522
[TBL] [Abstract][Full Text] [Related]
32. Solubilization of inclusion body proteins using n-propanol and its refolding into bioactive form.
Singh SM; Sharma A; Upadhyay AK; Singh A; Garg LC; Panda AK
Protein Expr Purif; 2012 Jan; 81(1):75-82. PubMed ID: 21964443
[TBL] [Abstract][Full Text] [Related]
33. [On-column refolding and purification of human EGF receptor L2 domain inclusion body overexpressed in Escherichia coli].
Xu LH; Hong A; He XH
Sheng Wu Gong Cheng Xue Bao; 2005 Jul; 21(4):597-603. PubMed ID: 16176099
[TBL] [Abstract][Full Text] [Related]
34. [Evaluation of three in-vitro refolding methods for human-derived anti-CTLA4 scFv expressed in E. coli].
Huang Q; Chen L; Zeng L; Wan L; Li S; Lu X; Cheng J
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Apr; 23(2):388-91. PubMed ID: 16706373
[TBL] [Abstract][Full Text] [Related]
35. Refolding and purification of recombinant human PDE7A expressed in Escherichia coli as inclusion bodies.
Richter W; Hermsdorf T; Kronbach T; Dettmer D
Protein Expr Purif; 2002 Jun; 25(1):138-48. PubMed ID: 12071709
[TBL] [Abstract][Full Text] [Related]
36. Purification and biological characterization of bacterially expressed recombinant buffalo prolactin.
Panchal M; Muralidhar K
Prep Biochem Biotechnol; 2010; 40(4):276-85. PubMed ID: 21108131
[TBL] [Abstract][Full Text] [Related]
37. Refolding and purification of Zymomonas mobilis levansucrase produced as inclusion bodies in fed-batch culture of recombinant Escherichia coli.
Sunitha K; Chung BH; Jang KH; Song KB; Kim CH; Rhee SK
Protein Expr Purif; 2000 Apr; 18(3):388-93. PubMed ID: 10733894
[TBL] [Abstract][Full Text] [Related]
38. An efficient in vitro refolding of recombinant bacterial laccase in Escherichia coli.
Mollania N; Khajeh K; Ranjbar B; Rashno F; Akbari N; Fathi-Roudsari M
Enzyme Microb Technol; 2013 May; 52(6-7):325-30. PubMed ID: 23608500
[TBL] [Abstract][Full Text] [Related]
39. Expression, purification, and in vitro refolding of soluble tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
Lin Z; Lei H; Cao P
Protein Expr Purif; 2007 Feb; 51(2):276-82. PubMed ID: 17079165
[TBL] [Abstract][Full Text] [Related]
40. A single freeze-thawing cycle for highly efficient solubilization of inclusion body proteins and its refolding into bioactive form.
Qi X; Sun Y; Xiong S
Microb Cell Fact; 2015 Feb; 14():24. PubMed ID: 25879903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
